Axsome Therapeutics, Inc. Gains 31.54%
Mon, Nov 28, 2022 at 07:17 PM
Axsome Therapeutics, Inc. (AXSM:NASDAQ) soared at $74.74, representing a gain of 31.5%. On Mon, Nov 28, 2022, AXSM:NASDAQ hit a New 2-Week High of $74.74. The stock appeared on our News Catalysts scanner on Mon, Nov 28, 2022 at 06:42 PM in the 'BIOTECH' category. From Mon, Nov 14, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
About Axsome Therapeutics, Inc. (AXSM:NASDAQ)
Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focusses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
Top 10 Gainers:
- Taboola.com Ltd. (TBLA:NASDAQ), 43.48%
- Tricida, Inc. (TCDA:NASDAQ), 38.72%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 31.54%
- Biophytis SA (BPTS:NASDAQ), 30.01%
- Bit Brother Limited (BTB:NASDAQ), 28.83%
- GigaCloud Technology Inc (GCT:NASDAQ), 28.73%
- Nutex Health Inc. (NUTX:NASDAQ), 28.1%
- Katapult Holdings Inc. (KPLT:NASDAQ), 22.93%
- Lion Group Holding Ltd. (LGHL:NASDAQ), 22.81%
- Nogin Inc. (NOGN:NASDAQ), 22.51%